goto Indian Health Service home page  Indian Health Service:  The Federal Health Program for American Indians and Alaska Natives

 
IHS HOME ABOUT IHS SITE MAP HELP
goto Health and Human Services home page goto Health and Human Services home page

Prenatal Genetic Screening – Serum and Ultrasound

Contact Us

MCH Website Administrator

Required Plugins

These plug-ins
may be required
for the content
on this page:


Link to Adobe Acrobat Plug-in Acrobat
Link to MicroSoft Word Plug-in MS Word

IHS Plug-in Page

Use site contact
if unable to view
a particular file

Maternal Child

Maternal Child HealthPerinatologist Corner ‹ C.E.U./C.M.E. Modules

Perinatologist Corner - C.E.U/C.M.E. Modules

Prenatal Genetic Screening – Serum and Ultrasound


Sponsored by The Indian Health Service Clinical Support Center

 

1 How to participate

For more details about how to participate in this C.E.U ./ C.M.E. program, see the Perinatologist Corner page. Also see specifics there on Goals, Sponsorship and Credit, and Disclosure .

Step 1: Goals and objectives

The student will understand the maternal and fetal consequences, methods and limitations of screening, and understand diabetes in pregnancy.

Objectives

The objectives for this module are:

  • The student will understand the maternal and fetal consequences of Prenatal Genetic Screening – Serum and Ultrasound
  • The student will understand the methods and limitations of Prenatal Genetic Screening – Serum and Ultrasound
  • The student will understand the management of Prenatal Genetic Screening – Serum and Ultrasound

Case scenario 

Ms. T. is a 19 y/o G1P0 at 15 weeks gestation. Her multiple marker screen returns positive for fetal neural tube defect (NTD) on the basis of an elevated maternal serum alpha-fetoprotein (AFP) of 4.23 MoM (multiples of the median). What constitutes appropriate management and counseling at this point?

 

Next › 2. Background

up arrow Return to top of page

This file last modified: Tuesday July 10, 2007  7:48 AM